Please assess the completion status of the following clinical trial:

Trial Title: Chronotherapy in Acute Multiple Sclerosis (MS) Attack

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Relapsing remitting MS~* EDSS-score before the actual attack \< 6.0~* Acute MS-attack with indication for treatment with steroids~* Symptoms \>24 hours \< 4 weeks~* Age 18 years or older~Exclusion Criteria:~* Prior enrollment in this study~* Ongoing serious infection that is a contraindication for treatment with steroids~* Pregnancy~* Medical situations (prior acute diseases) where treatment with intravenous steroids over short period of time is contraindicated or not favorable.~* Enhanced cognitive dysfunction~* Treatment with p.o or i.v steroids within 3 weeks prior to date of inclusion

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Both study arms receive both active treatment = methylprednisolone and an inactive treatment = Sodium chlorid (dummy)
- 2 (Type: ACTIVE_COMPARATOR): Both arms receives both active treatment and inactive treatment = dummy. Active treatment is methylprednisolone, inactive treatment is sodium chlorid.

Based on this trial design, predict the completion outcome and termination type (if applicable).